Market access and HTA – a snapshot of recent developments with Sreeram Ramagopalan: July–September 2023

6 Nov 2023

Written by Sreeram Ramagopalan (Lane Clark & Peacock)

Guest columns Health economics Health technology assessment Industry Updates Interviews Journal articles Market access Value assessment

Read highlights from the latest instalment of Sreeram Ramagopalan’s (Lane Clark & Peacock, UK) industry news round-up, which reviews recent developments in market access and health technology assessment, and is published bi-monthly in our partner journal, the Journal of Comparative Effectiveness Research. Read the full update in the Journal of Comparative Effectiveness Research here >>> What happened over these months that you were expecting? The US Inflation Reduction Act (IRA) allows Medicare to negotiate drug prices with pharmaceutical manufacturers. Medicare, the largest purchaser of prescription drugs in the US, was previously prohibited from directly negotiating drug prices. The IRA authorizes...